Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancerMILES, D. W ; FOGARTY, O ; ASH, C. M ; RUDD, R. M ; TRASK, C. W. L ; SPIRO, S. G ; LEDERMANN, G. J. A ; SOUHAMI, R. L ; HARPER, P. GJournal of clinical oncology, 1994-01, Vol.12 (1), p.77-82 [Periódico revisado por pares]Baltimore, MD: American Society of Clinical OncologySem texto completo |
|
2 |
Material Type: Artigo
|
A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trialJAMES, L. E ; GOWER, N. H ; RUDD, R. M ; SPIRO, S. G ; HARPER, P. G ; TRASK, C. W ; PARTRIDGE, M ; RUIZ DE ELVIRA, M.-C ; SOUHAMI, R. LBritish journal of cancer, 1996-06, Vol.73 (12), p.1563-1568 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
3 |
Material Type: Artigo
|
A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervixCOLEMAN, R. E ; HARPER, P. G ; WILTSHAW, E ; GALLAGHER, C ; OSBORNE, R ; RANKIN, E. M ; SILVERSTONE, A. C ; SLEVIN, M. L ; SOUHAMI, R. L ; TOBIAS, J. S ; TRASK, C. WCancer chemotherapy and pharmacology, 1986-01, Vol.18 (3), p.280-283 [Periódico revisado por pares]Berlin: SpringerTexto completo disponível |
|
4 |
Material Type: Artigo
|
Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy?Oliver, R.T.D. ; Edmonds, P.M. ; Ong, J.Y.H. ; Ostrowski, M.J. ; Jackson, A.W. ; Baille-Johnson, H. ; Williams, M.V. ; Wiltshire, C.R. ; Mott, T. ; Pratt, W.R. ; Trask, C.W.L. ; Hope-Stone, H.F.International journal of radiation oncology, biology, physics, 1994-04, Vol.29 (1), p.3-8 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
|
5 |
Material Type: Artigo
|
ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancerThe ICON CollaboratorsThe Lancet (British edition), 1998-11, Vol.352 (9140), p.1571-1576 [Periódico revisado por pares]London: Elsevier LtdTexto completo disponível |